TPIDB > Principal Investigator
Principal Investigator
更新時間：2023-09-19
陳俊賓Chen, Chun-Bing
- Principal Investigator
- Clinical Trial Experience (year) 17 years 9 個月
-
chunbing.chen@gmail.com
Publication
48Publications
21
Chan CJ, Wang HQ, Zhang J, Zou Y, Zhang YH, Chen JW, Chen CB Chung WH, JC. Distinct Proteomic Profiling of Plasma Extracellular Vesicles from Moderate-to-Severe Atopic Dermatitis Patients. Clin Cosmet Investig Dermatol. 2021 Aug 25;14:1033-1043. (SCI, IF= 2.765, Dermatology 36/69= 52.2%)
22
Chu MT, Wang CW, Chang WC, Chen CB, Chung WH, Hung SI. Granulysin-Based Lymphocyte Activation Test for Evaluating Drug Causality in Antiepileptics-Induced Severe Cutaneous Adverse Reactions. J Invest Dermatol. 2021 Jun;141(6):1461-1472.e10. (SCI, IF= 8.551, Dermatology 11/69= 15.9%)
23
Yang SC, Chen CB, Lin MY, Zhang ZY, Jia XY, Huang M, Zou YF, Chung WH. Genetics of Severe Cutaneous Adverse Reactions. Frontiers in Medicine (Lausanne). 2021 Jul 15;8:652091. (SCI, IF=5.058, Medicine, general & internals 52/172=30.2%)
24
Chiang PH, Ng CY, Kuo TT, Hui R.CY, Chen CB, Lu CW, Chung WH. Case of vitiligo universalis as a sequela of drug-induced hypersensitivity syndrome. Journal of Dermatology. 2021 Jan;48(1):92-95. (SCI, IF= 3.468, Dermatology 22/69= 31.9%)
25
Chen CB*, Kuo KL, Wang CW, Lu CW, Hui ,Rosaline CY, Lu KL, Chang WC, Chen WT, Yun F, Teng YC, Lee HE, Lin JY, Ho HC, Chi MH, Lin ,Yang YW, Chang CJ, Lin JY, Ku CL, Hung SI, Chang YC, Chung WH, for the Taiwan Severe Cutaneous Adverse Reaction Consortium. Detecting Lesional Granulysin Levels for Rapid Diagnosis of Cytotoxic T lymphocytes-mediated Bullous Skin Disorders. J Allergy Clin Immunol Pract. 2021 Mar;9(3):1327-1337.e3. (SCI, IF=11.022, Allergy 3/28=10.7%) (Immunology 19/162=11.7%) MOST 108-2314-B-182A-006-MY2
26
Wang CW, Tassaneeyakul W, Chen CB, Chen WT, Teng YC, Huang CY, Sukasem C, Lu CW, Lee YS, Choon SE, Nakkam N, Hui ,Rosaline CY , Huang YH, Chang YC, Lin YW, Chang CJ, Chiu TM, Chantratita W, Konyoung P, Lee CN, Klaewsongkram J, Rerkpattanapipat T, Amornpinyo W, Saksit N, Rerknimitr P, Huei HY, Lin SH, Hsu CK, Fan WL, Chan CC, Lin YJ, Hung SI, Chung WH; Taiwan/Asian Severe Cutaneous Adverse Reaction Consortium. Whole Genome Sequencing Identifies Genetic Variants Associated with Co-trimoxazole Hypersensitivity in Asians. J Allergy Clin Immunol. 2021 Apr;147(4):1402-1412 (SCI, IF=14.29, Allergy 2/27=7.4%) (Immunology 17/162=10.5%)
27
Chen CB*, Chung WH. Current agreement on the management of Stevens-Johnson syndrome and toxic epidermal necrolysis. Br J Dermatol. 2021 Sep; 185(3):484-486. (SCI, IF=11.113, Dermatology 3/69=4.3%)
28
Su HJ, Chen CB*, Yeh TY, Wang CW, Hui Rosaline CY, Lu CW, Chen WT, Chang YC, Lin JY, Ho HC, Lin,Yang YW, Chang CJ, Chung WH. Successful treatment of corticosteroid-dependent drug reaction with eosinophilia and systemic symptoms with cyclosporine. Ann Allergy Asthma Immunol. 2021 Dec;127(6):674-681. (SCI, IF=6.248, Allergy 9/27=33.3%) (Immunology 52/162=32.1%) (Co-first author)
29
Ma KS, Saeed HN, Chodosh J, Wang CW, Chung YC, Wei LC, Kuo MT, Liang CM, Chang JW, Chung WH, Chen CB*, Ma DH. Ocular manifestations of anti-neoplastic immune checkpoint inhibitor-associated Stevens-Johnson syndrome/toxic epidermal necrolysis in cancer patients. Ocul Surf. 2021 Jun 30;22:47-50. (SCI, IF=5.033, Ophthalmology 5/61=8.2%) (Co-corresponding author)
30
Chen CB*, Chen YE, Chu MT, Wan CW, Hui Rosaline CY, Lu CW , Hsiao YP, Chu CY, Chang MM, Cheung Christina MT, Cheng CY, Wang YW, Li YJ , Chang CJ, Hung SI, Chung WH. The risk of anti-osteoporotic agent-induced severe cutaneous adverse drug reactions and their association with HLA. Journal of the European Academy of Dermatology and Venereology. 2021 Mar;35(3):712-720. (SCI, IF= 9.228, Dermatology 4/69=5.8%)
